Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015

Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Abate KH, Akinyemiju TF, Ali R, et al. (2017)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 317(2): 165-182.

Download
No fulltext has been uploaded. References only!
Journal Article | Original Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ; ; ; ;
All
Abstract
IMPORTANCE Elevated systolic blood (SBP) pressure is a leading global health risk. Quantifying the levels of SBP is important to guide prevention policies and interventions. OBJECTIVE To estimate the association between SBP of at least 110 to 115 mm Hg and SBP of 140 mm Hg or higher and the burden of different causes of death and disability by age and sex for 195 countries and territories, 1990-2015. DESIGN A comparative risk assessment of health loss related to SBP. Estimated distribution of SBP was based on 844 studies from 154 countries (published 1980-2015) of 8.69 million participants. Spatiotemporal Gaussian process regression was used to generate estimates of mean SBP and adjusted variance for each age, sex, country, and year. Diseases with sufficient evidence for a causal relationship with high SBP (eg, ischemic heart disease, ischemic stroke, and hemorrhagic stroke) were included in the primary analysis. MAIN OUTCOMES AND MEASURES Mean SBP level, cause-specific deaths, and health burden related to SBP (>110-115mmHg and also >= 140 mm Hg) by age, sex, country, and year. RESULTS Between 1990-2015, the rate of SBP of at least 110 to 115 mm Hg increased from 73 119 (95% uncertainty interval [UI], 67 949-78 241) to 81 373 (95% UI, 76 814-85 770) per 100000, and SBP of 140 mm Hg or higher increased from 17 307 (95% UI, 17 117-17 492) to 20526 (95% UI, 20283-20746) per 100000. The estimated annual death rate per 100000 associated with SBP of at least 110 to 115 mm Hg increased from 135.6 (95% UI, 122.4-148.1) to 145.2 (95% UI 130.3-159.9) and the rate for SBP of 140 mm Hg or higher increased from 97.9 (95% UI, 87.5-108.1) to 106.3 (95% UI, 94.6-118.1). Loss of disability-adjusted life-years (DALYs) associated with SBP of at least 110 to 115 mm Hg increased from 148 million (95% UI, 134-162 million) to 211 million (95% UI, 193-231 million), and for SBP of 140 mm Hg or higher, the loss increased from 5.2 million (95% UI, 4.6-5.7 million) to 7.8 million (95% UI, 7.0-8.7 million). The largest numbers of SBP-related deathswere caused by ischemic heart disease (4.9 million [95% UI, 4.0-5.7 million]; 54.5%), hemorrhagic stroke (2.0million [95% UI, 1.6-2.3 million]; 58.3%), and ischemic stroke (1.5 million [95% UI, 1.2-1.8 million]; 50.0%). In 2015, China, India, Russia, Indonesia, and the United States accounted for more than half of the global DALYs related to SBP of at least 110 to 115 mm Hg. CONCLUSIONS AND RELEVANCE In international surveys, although there is uncertainty in some estimates, the rate of elevated SBP (>= 110-115 and >= 140 mm Hg) increased substantially between 1990 and 2015, and DALYs and deaths associated with elevated SBP also increased. Projections based on this sample suggest that in 2015, an estimated 3.5 billion adults had SBP of at least 110 to 115 mm Hg and 874 million adults had SBP of 140 mm Hg or higher. Copyright 2016 American Medical Association. All rights reserved.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Forouzanfar MH, Liu P, Roth GA, et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2017;317(2):165-182.
Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., Alexander, L., et al. (2017). Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 317(2), 165-182. doi:10.1001/jama.2016.19043
Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., Alexander, L., Estep, K., Abate, K. H., Akinyemiju, T. F., et al. (2017). Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 317, 165-182.
Forouzanfar, M.H., et al., 2017. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 317(2), p 165-182.
M.H. Forouzanfar, et al., “Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015”, JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, vol. 317, 2017, pp. 165-182.
Forouzanfar, M.H., Liu, P., Roth, G.A., Ng, M., Biryukov, S., Marczak, L., Alexander, L., Estep, K., Abate, K.H., Akinyemiju, T.F., Ali, R., Alvis-Guzman, N., Azzopardi, P., Banerjee, A., Baernighausen, T., Basu, A., Bekele, T., Bennett, D.A., Biadgilign, S., Catala-Lopez, F., Feigin, V.L., Fernandes, J.C., Fischer, F., Gebru, A.A., Gona, P., Gupta, R., Hankey, G.J., Jonas, J.B., Judd, S.E., Khang, Y.-H., Khosravi, A., Kim, Y.J., Kimokoti, R.W., Kokubo, Y., Kolte, D., Lopez, A., Lotufo, P.A., Malekzadeh, R., Melaku, Y.A., Mensah, G.A., Misganaw, A., Mokdad, A.H., Moran, A.E., Nawaz, H., Neal, B., Ngalesoni, F.N., Ohkubo, T., Pourmalek, F., Rafay, A., Rai, R.K., Rojas-Rueda, D., Sampson, U.K., Santos, I.S., Sawhney, M., Schutte, A.E., Sepanlou, S.G., Shifa, G.T., Shiue, I., Tedla, B.A., Thrift, A.G., Tonelli, M., Truelsen, T., Tsilimparis, N., Ukwaja, K.N., Uthman, O.A., Vasankari, T., Venketasubramanian, N., Vlassov, V.V., Vos, T., Westerman, R., Yan, L.L., Yano, Y., Yonemoto, N., Zaki, M.E.S., Murray, C.J.L.: Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 317, 165-182 (2017).
Forouzanfar, Mohammad H., Liu, Patrick, Roth, Gregory A., Ng, Marie, Biryukov, Stan, Marczak, Laurie, Alexander, Lily, Estep, Kara, Abate, Kalkidan Hassen, Akinyemiju, Tomi F., Ali, Raghib, Alvis-Guzman, Nelson, Azzopardi, Peter, Banerjee, Amitava, Baernighausen, Till, Basu, Arindam, Bekele, Tolesa, Bennett, Derrick A., Biadgilign, Sibhatu, Catala-Lopez, Ferran, Feigin, Valery L., Fernandes, Joao C., Fischer, Florian, Gebru, Alemseged Aregay, Gona, Philimon, Gupta, Rajeev, Hankey, Graeme J., Jonas, Jost B., Judd, Suzanne E., Khang, Young-Ho, Khosravi, Ardeshir, Kim, Yun Jin, Kimokoti, Ruth W., Kokubo, Yoshihiro, Kolte, Dhaval, Lopez, Alan, Lotufo, Paulo A., Malekzadeh, Reza, Melaku, Yohannes Adama, Mensah, George A., Misganaw, Awoke, Mokdad, Ali H., Moran, Andrew E., Nawaz, Haseeb, Neal, Bruce, Ngalesoni, Frida Namnyak, Ohkubo, Takayoshi, Pourmalek, Farshad, Rafay, Anwar, Rai, Rajesh Kumar, Rojas-Rueda, David, Sampson, Uchechukwu K., Santos, Itamar S., Sawhney, Monika, Schutte, Aletta E., Sepanlou, Sadaf G., Shifa, Girma Temam, Shiue, Ivy, Tedla, Bemnet Amare, Thrift, Amanda G., Tonelli, Marcello, Truelsen, Thomas, Tsilimparis, Nikolaos, Ukwaja, Kingsley Nnanna, Uthman, Olalekan A., Vasankari, Tommi, Venketasubramanian, Narayanaswamy, Vlassov, Vasiliy Victorovich, Vos, Theo, Westerman, Ronny, Yan, Lijing L., Yano, Yuichiro, Yonemoto, Naohiro, Zaki, Maysaa El Sayed, and Murray, Christopher J. L. “Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015”. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 317.2 (2017): 165-182.
This data publication is cited in the following publications:
This publication cites the following data publications:

50 Citations in Europe PMC

Data provided by Europe PubMed Central.

Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial.
de Jager RL, van Maarseveen EM, Bots ML, Blankestijn PJ, SYMPATHY investigators., Br J Clin Pharmacol 84(1), 2018
PMID: 28815689
Trends in the prevalence of antihypertensive drug treatment in the Beijing Longitudinal Study of Aging.
Ma L, Han R, Li L, Li Z, Sun F, Diao L, Tang Z., Arch Gerontol Geriatr 74(), 2018
PMID: 28957687
Diabetes treatment over age 65: Is worse control really better?
Bloomgarden Z, Mende C, Einhorn D, Handelsman Y., J Diabetes 9(5), 2017
PMID: 28133929
From the Editor.
Levy D., J Am Soc Hypertens 11(3), 2017
PMID: 28454770
Clinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation.
Morales Salinas A, Coca A, Olsen MH, Sanchez RA, Sebba-Barroso WK, Kones R, Bertomeu-Martinez V, Sobrino J, Alcocer L, Pineiro DJ, Lanas F, Machado CA, Aguirre-Palacios F, Ortellado J, Perez G, Sabio R, Landrove O, Rodriguez-Leyva D, Duenas-Herrera A, Rodriguez Portelles A, Parra-Carrillo JZ, Piskorz DL, Bryce-Moncloa A, Waisman G, Yano Y, Ventura H, Orias M, Prabhakaran D, Sundström J, Wang J, Burrell LM, Schutte AE, Lopez-Jaramillo P, Barbosa E, Redon J, Weber MA, Lavie CJ, Ramirez A, Ordunez P, Yusuf S, Zanchetti A., Curr Probl Cardiol 42(7), 2017
PMID: 28552207
The 2017 Focused Update of the Guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the Management of Hypertension.
Chiang CE, Wang TD, Lin TH, Yeh HI, Liu PY, Cheng HM, Chao TH, Chen CH, Shyu KG, Ueng KC, Chen CY, Chu PH, Sung SH, Wang KL, Li YH, Wang KY, Chiang FT, Lai WT, Chen JH, Chen WJ, Yeh SJ, Chen MF, Lin SJ, Lin JL., Acta Cardiol Sin 33(3), 2017
PMID: 28559651
From the Editor.
Levy D., J Am Soc Hypertens 11(5), 2017
PMID: 28595739
Diagnosis, Prevalence, Awareness, Treatment, Prevention, and Control of Hypertension in Cameroon: Protocol for a Systematic Review and Meta-Analysis of Clinic-Based and Community-Based Studies.
Kuate Defo B, Mbanya JC, Tardif JC, Ekundayo O, Perreault S, Potvin L, Cote R, Kengne AP, Choukem SP, Assah F, Kingue S, Richard L, Pongou R, Frohlich K, Saji J, Fournier P, Sobngwi E, Ridde V, Dubé MP, De Denus S, Mbacham W, Lafrance JP, Nsagha DS, Mampuya W, Dzudie A, Cloutier L, Zarowsky C, Tanya A, Ndom P, Hatem M, Rey E, Roy L, Borgès Da Silva R, Dagenais C, Todem D, Weladji R, Mbanya D, Emami E, Njoumemi Z, Monnais L, Dubois CA., JMIR Res Protoc 6(5), 2017
PMID: 28554882
Isometric Handgrip as an Adjunct for Blood Pressure Control: a Primer for Clinicians.
McGowan CL, Proctor DN, Swaine I, Brook RD, Jackson EA, Levy PD., Curr Hypertens Rep 19(6), 2017
PMID: 28528376
Hypertension: Overly important but under-controlled.
van Kleef ME, Spiering W., Eur J Prev Cardiol 24(3_suppl), 2017
PMID: 28618912
Multicomponent intervention versus usual care for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: study protocol for a cluster randomized controlled trial.
Jafar TH, Jehan I, de Silva HA, Naheed A, Gandhi M, Assam P, Finkelstein EA, Quigley HL, Bilger M, Khan AH, Clemens JD, Ebrahim S, Turner EL, for COBRA-BPS Study Group, Kasturiratne A., Trials 18(1), 2017
PMID: 28606184
Aging and obesity are associated with undiagnosed hypertension in a cohort of males in the Central Province of Sri Lanka: a cross-sectional descriptive study.
Jayawardana NWIA, Jayalath WATA, Madhujith WMT, Ralapanawa U, Jayasekera RS, Alagiyawanna SASB, Bandara AMKR, Kalupahana NS., BMC Cardiovasc Disord 17(1), 2017
PMID: 28637427
Changes in hypertension prevalence, awareness, treatment and control rates over 20 years in National Capital Region of India: results from a repeat cross-sectional study.
Roy A, Praveen PA, Amarchand R, Ramakrishnan L, Gupta R, Kondal D, Singh K, Sharma M, Shukla DK, Tandon N, Reddy KS, Krishnan A, Prabhakaran D., BMJ Open 7(7), 2017
PMID: 28706098
Gender-specific associations between serum isomers of perfluoroalkyl substances and blood pressure among Chinese: Isomers of C8 Health Project in China.
Bao WW, Qian ZM, Geiger SD, Liu E, Liu Y, Wang SQ, Lawrence WR, Yang BY, Hu LW, Zeng XW, Dong GH., Sci Total Environ 607-608(), 2017
PMID: 28738507
Hypertension and Cardiovascular Risk Profile in a Middle-Income Setting: The HELISUR Study.
Diemer FS, Baldew SM, Haan YC, Aartman JQ, Karamat FA, Nahar-van Venrooij LMW, van Montfrans GA, Oehlers GP, Brewster LM., Am J Hypertens 30(11), 2017
PMID: 28985247
Cardio-Metabolic Benefits of Plant-Based Diets.
Kahleova H, Levin S, Barnard N., Nutrients 9(8), 2017
PMID: 28792455
Quantifying unmet need for hypertension care in South Africa through a care cascade: evidence from the SANHANES, 2011-2012.
Berry KM, Parker WA, Mchiza ZJ, Sewpaul R, Labadarios D, Rosen S, Stokes A., BMJ Glob Health 2(3), 2017
PMID: 29082013
Impact of the National Essential Public Health Services Policy on Hypertension Control in China.
Zhang D, Pan X, Li S, Liang D, Hou Z, Li Y, Shi L., Am J Hypertens 31(1), 2017
PMID: 28985269
Diabetes and Hypertension: A Position Statement by the American Diabetes Association.
de Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, Rossing P, Zoungas S, Bakris G., Diabetes Care 40(9), 2017
PMID: 28830958
Assessing healthcare professional knowledge, attitudes, and practices on hypertension management. Announcing a new World Hypertension League resource.
Campbell NRC, Dashdorj N, Baatarsuren U, Myanganbayar M, Dashtseren M, Unurjargal T, Zhang XH, Veiga EV, Beheiry HM, Mohan S, Almustafa B, Niebylski M, Lackland D., J Clin Hypertens (Greenwich) 19(9), 2017
PMID: 28921922
Thus Far and No Further: Should Diastolic Hypotension Limit Intensive Blood Pressure Lowering?
Ruzicka M, Edwards C, McCormick B, Hiremath S., Curr Treat Options Cardiovasc Med 19(10), 2017
PMID: 28913677
Powdered chicken stock may be an important source of dietary sodium intake in Maputo, Mozambique.
Sousa S, Damasceno A, Gelormini M, Jessen N, Lunet N, Padrão P., J Public Health (Oxf) (), 2017
PMID: 28977456

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 28097354
PubMed | Europe PMC

Search this title in

Google Scholar